Professor of Medicine, Emeritus, Brigham and Women's Hospital
Cardiology
Dr. Arthur A. Sasahara, MD
|
|
Give Review
Dr. Arthur A. Sasahara practices Cardiology. He went to Case Western Reserve University School of Medicine. He has 2 awards "Whos Who in Medicine and Healthcare" and "Fellow (FACC)". Arthur A. Sasahara is a published doctor. He has 51 publications published. The most current publication "A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery ..."
Publications
- THE NATF CORNER.
- Hemodynamic and ventricular responses to pulmonary embolism.
- Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators.
- Clinical studies with the new glycosylated recombinant prourokinase.
- New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarction. Prourokinase Study Group.
- Effect of recombinant-tissue plasminogen activator, low molecular weight urokinase and unfractionated heparin on platelet aggregation.
- Clinical and hemodynamic correlates in pulmonary embolism.
- Pulmonary vascular responses to thromboembolism.
- Pulmonary thromboembolism: current concepts.
- [Does thrombolytic treatment modify the prognosis of pulmonary embolism?].
- Pulmonary embolism: the great imitator.
- Letter: Low-dose heparin.
- Interaction between human platelet factor 4 and protamine sulfate in the presence of a low molecular weight heparin in the rabbit.
- Determinants of right ventricular function and hemodynamics after pulmonary embolism.
- United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis.
- Management of pulmonary embolism in the postoperative patient.
- The ratio of pulmonary arterial pressure to pulmonary vascular obstruction: index of preembolic cardiopulmonary status.
- A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery ...
- Approach to the patient with venous thromboembolism. Treatment with thrombolytic agents.
- Urokinase therapy in clinical pulmonary embolism. A new thrombolytic agent.
- Urokinase in thromboembolic disease: Pulmonary embolism.
- A national cooperative trial of thrombolysis in pulmonary embolism: phase I results of urokinase therapy.
- Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders.
- Enhancement of the thrombolytic efficacy of prourokinase by lys-plasminogen in a dog model of arterial thrombosis.
- Serial determinations of PF4 and beta TG: comparisons between multiple venipunctures vs a catheter infusion system.
- Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
- Fibrinolytic guidelines in diabetes.
- Clinical use of thrombolytic agents in venous thromboembolism.
- The electrocardiogram in acute pulmonary embolism.
- Relation of the electrocardiogram to hemodynamic alterations in pulmonary embolism.
- Hemodynamic alterations related to extent of lung scan perfusion defect in pulmonary embolism.
- Platelet activation with unfractionated heparin at therapeutic concentrations and comparison with low-molecular-weight heparin and with a direct thrombin inhibitor.
- Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.
- Therapy for pulmonary embolism.
- New developments in the detection and prevention of venous thromboembolism.
- Controversies of different regimens of thrombolytic therapy in acute pulmonary embolism.
- The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease.
- Pulmonary thromboembolism. Diagnosis and treatment.
- Prospective study of a standardized questionnaire to improve clinical estimate of pulmonary embolism.
- Long-term benefit of thrombolytic therapy in patients with pulmonary embolism.
- Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence.
- Assessing the risk of venous thromboembolism and identifying barriers to thromboprophylaxis in the hospitalized patient.
- Improving thromboprophylaxis: performance measures and practical strategies.
- Optimizing management of venous thromboembolism: diagnosis, treatment, and secondary prevention.
- Guidelines-based use of thromboprophylaxis.
- The immunogenic potential of generic version of low-molecular-weight heparins may not be the same as the branded products.
- Potential thrombogenic complications with the use of recombinant activated factor VII in combat trauma.
- Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism.
- Enoxaparin monotherapy without oral anticoagulation to treat acute symptomatic pulmonary embolism.
- Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy?
Schools
Case Western Reserve University School of Medicine
Boston City Hospital
Massachusetts General Hospital
Doctors Specialties
- Internal Medicine
- Cardiology
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
- Fellow (FACC)
Education
-
Yale-New Haven Hospital -
Boston Children's Hospital -
Massachusetts General Hospital -
Boston University Medical Center -
Case Western Reserve University School of Medicine
Hospital
-
Brigham and Women's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Randy J. Averback, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel B. Levy, MD |
|
|
Dr. Mark R. Goldman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brenda E. Corrigan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohamad R. El-Zaru, MD |
|
|
Dr. Steven B. Pestka, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine M. Combs, MD
This Doctor is OpenDoctor Recommended.
|